Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma
- 1 May 2015
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 115 (2) , 179-185
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- First experiences in treatment of low-grade glioma grade I and II with proton therapyRadiation Oncology, 2012
- A Review of Update Clinical Results of Carbon Ion RadiotherapyJapanese Journal of Clinical Oncology, 2012
- Range uncertainties in proton therapy and the role of Monte Carlo simulationsPhysics in Medicine & Biology, 2012
- Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA studyBMC Cancer, 2012
- Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study conceptsRadiation Oncology, 2012
- Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA TrialBMC Cancer, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Patient Study of In Vivo Verification of Beam Delivery and Range, Using Positron Emission Tomography and Computed Tomography Imaging After Proton TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo codePhysics in Medicine & Biology, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005